vs
DULUTH HOLDINGS INC.(DLTH)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
DULUTH HOLDINGS INC.的季度营收约是RIGEL PHARMACEUTICALS INC的1.6倍($114.9M vs $69.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs -8.8%,领先392.8%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs -9.6%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs -31.6%)
德卢思控股是一家美国工装及配饰企业,主打通过旗下德卢思贸易品牌开展产品销售业务,面向市场推出各类实用工装及相关配饰产品,是美国本土颇具特色的服饰零售企业。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
DLTH vs RIGL — 直观对比
营收规模更大
DLTH
是对方的1.6倍
$69.8M
营收增速更快
RIGL
高出30.8%
-9.6%
净利率更高
RIGL
高出392.8%
-8.8%
两年增速更快
RIGL
近两年复合增速
-31.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $114.9M | $69.8M |
| 净利润 | $-10.1M | $268.1M |
| 毛利率 | 53.8% | 91.5% |
| 营业利润率 | -7.7% | 33.2% |
| 净利率 | -8.8% | 384.0% |
| 营收同比 | -9.6% | 21.2% |
| 净利润同比 | 64.6% | 1769.2% |
| 每股收益(稀释后) | $-0.29 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DLTH
RIGL
| Q4 25 | $114.9M | $69.8M | ||
| Q3 25 | $131.7M | $69.5M | ||
| Q2 25 | $102.7M | $101.7M | ||
| Q1 25 | $241.3M | $53.3M | ||
| Q4 24 | $127.1M | $57.6M | ||
| Q3 24 | $141.6M | $55.3M | ||
| Q2 24 | $116.7M | $36.8M | ||
| Q1 24 | $245.6M | $29.5M |
净利润
DLTH
RIGL
| Q4 25 | $-10.1M | $268.1M | ||
| Q3 25 | $1.3M | $27.9M | ||
| Q2 25 | $-15.3M | $59.6M | ||
| Q1 25 | $-5.6M | $11.4M | ||
| Q4 24 | $-28.2M | $14.3M | ||
| Q3 24 | $-2.0M | $12.4M | ||
| Q2 24 | $-7.9M | $-1.0M | ||
| Q1 24 | $6.4M | $-8.2M |
毛利率
DLTH
RIGL
| Q4 25 | 53.8% | 91.5% | ||
| Q3 25 | 54.7% | 93.2% | ||
| Q2 25 | 52.0% | 95.6% | ||
| Q1 25 | 44.1% | 91.7% | ||
| Q4 24 | 52.3% | 89.9% | ||
| Q3 24 | 52.3% | 85.5% | ||
| Q2 24 | 52.8% | 92.4% | ||
| Q1 24 | 48.2% | 93.1% |
营业利润率
DLTH
RIGL
| Q4 25 | -7.7% | 33.2% | ||
| Q3 25 | 1.8% | 40.9% | ||
| Q2 25 | -12.0% | 60.1% | ||
| Q1 25 | -1.8% | 23.9% | ||
| Q4 24 | -17.4% | 28.9% | ||
| Q3 24 | -1.1% | 25.4% | ||
| Q2 24 | -7.7% | 1.2% | ||
| Q1 24 | 3.6% | -23.6% |
净利率
DLTH
RIGL
| Q4 25 | -8.8% | 384.0% | ||
| Q3 25 | 1.0% | 40.2% | ||
| Q2 25 | -14.9% | 58.6% | ||
| Q1 25 | -2.3% | 21.5% | ||
| Q4 24 | -22.2% | 24.9% | ||
| Q3 24 | -1.4% | 22.5% | ||
| Q2 24 | -6.7% | -2.8% | ||
| Q1 24 | 2.6% | -27.9% |
每股收益(稀释后)
DLTH
RIGL
| Q4 25 | $-0.29 | $14.11 | ||
| Q3 25 | $0.04 | $1.46 | ||
| Q2 25 | $-0.45 | $3.28 | ||
| Q1 25 | $-0.17 | $0.63 | ||
| Q4 24 | $-0.84 | $0.82 | ||
| Q3 24 | $-0.06 | $0.70 | ||
| Q2 24 | $-0.24 | $-0.06 | ||
| Q1 24 | $0.20 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $8.2M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $160.6M | $391.5M |
| 总资产 | $468.0M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
DLTH
RIGL
| Q4 25 | $8.2M | $155.0M | ||
| Q3 25 | $5.7M | $137.1M | ||
| Q2 25 | $8.6M | $108.4M | ||
| Q1 25 | $3.3M | $77.1M | ||
| Q4 24 | $9.3M | $77.3M | ||
| Q3 24 | $9.8M | $61.1M | ||
| Q2 24 | $6.8M | $49.1M | ||
| Q1 24 | $32.2M | $49.5M |
总债务
DLTH
RIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益
DLTH
RIGL
| Q4 25 | $160.6M | $391.5M | ||
| Q3 25 | $170.0M | $117.6M | ||
| Q2 25 | $167.9M | $81.9M | ||
| Q1 25 | $182.7M | $18.6M | ||
| Q4 24 | $188.1M | $3.3M | ||
| Q3 24 | $215.7M | $-14.6M | ||
| Q2 24 | $218.4M | $-29.9M | ||
| Q1 24 | $222.8M | $-31.7M |
总资产
DLTH
RIGL
| Q4 25 | $468.0M | $513.6M | ||
| Q3 25 | $433.8M | $242.5M | ||
| Q2 25 | $463.7M | $206.7M | ||
| Q1 25 | $452.4M | $176.0M | ||
| Q4 24 | $533.1M | $164.0M | ||
| Q3 24 | $488.6M | $139.4M | ||
| Q2 24 | $471.4M | $128.4M | ||
| Q1 24 | $491.2M | $126.5M |
负债/权益比
DLTH
RIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-6.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | — |
| 自由现金流率自由现金流/营收 | -7.8% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $1.7M | — |
8季度趋势,按日历期对齐
经营现金流
DLTH
RIGL
| Q4 25 | $-6.7M | $22.0M | ||
| Q3 25 | $32.0M | $24.0M | ||
| Q2 25 | $-56.5M | $30.5M | ||
| Q1 25 | $41.2M | $-893.0K | ||
| Q4 24 | $-41.1M | $14.5M | ||
| Q3 24 | $16.6M | $21.7M | ||
| Q2 24 | $-33.7M | $302.0K | ||
| Q1 24 | $69.7M | $-5.0M |
自由现金流
DLTH
RIGL
| Q4 25 | $-8.9M | — | ||
| Q3 25 | $29.8M | — | ||
| Q2 25 | $-57.8M | — | ||
| Q1 25 | $38.7M | — | ||
| Q4 24 | $-43.7M | — | ||
| Q3 24 | $15.0M | — | ||
| Q2 24 | $-35.2M | — | ||
| Q1 24 | $60.6M | — |
自由现金流率
DLTH
RIGL
| Q4 25 | -7.8% | — | ||
| Q3 25 | 22.6% | — | ||
| Q2 25 | -56.3% | — | ||
| Q1 25 | 16.0% | — | ||
| Q4 24 | -34.4% | — | ||
| Q3 24 | 10.6% | — | ||
| Q2 24 | -30.2% | — | ||
| Q1 24 | 24.7% | — |
资本支出强度
DLTH
RIGL
| Q4 25 | 2.0% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 3.7% | — |
现金转化率
DLTH
RIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 25.40× | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.86× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DLTH
| Sales Channel Directly To Consumer | $67.4M | 59% |
| Sales Channel Through Intermediary | $47.4M | 41% |
RIGL
暂无分部数据